Shots: Alnylam to add an additional investigational product through the end of IND-enabling studies in Sanofi’s subsidiary Genzyme and Alnylam in 2014 deal, where companies collaborated to develop and commercialize […]readmore
Tags : Exercise
Shots: AstraZeneca (AZ) will receive $5M option license fee and additional $20M on approval of Duaklir (aclidinium / formoterol) (product of AZ) from Circassia. Circassia to get US commercialization rights […]readmore